Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2026)
Elanco Animal Health's (ELAN) quarterly Non-Current Debt came in at $3.8 billion in Q2 2026, down 7.3% year-over-year from $4.1 billion in Q2 2025, and down 1.86% quarter-over-quarter from $3.9 billion in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Non-Current Debt across 9 years of filings, most recently posting $3.8 billion for Q2 2026.
- In Q2 2026, Non-Current Debt fell 7.3% year-over-year to $3.8 billion; the TTM figure through Jun 2026 stood at $3.8 billion (down 7.3% YoY), while the FY2025 annual figure was $3.9 billion, down 8.75% from the prior year.
- Non-Current Debt came in at $3.8 billion for Q2 2026 at Elanco Animal Health, down from $3.9 billion in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $6.1 billion in Q1 2022 to a low of $3.8 billion in Q2 2026.
- Average Non-Current Debt over 5 years is $5.0 billion, with a median of $5.1 billion recorded in 2024.
- Year-over-year, Non-Current Debt climbed 0.14% in 2023 and dropped 28.72% in 2024.
- Over 5 years, Non-Current Debt stood at $5.8 billion in 2022, then slipped by 1.06% to $5.8 billion in 2023, then fell by 25.16% to $4.3 billion in 2024, then dropped by 8.75% to $3.9 billion in 2025, then declined by 2.49% to $3.8 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $3.8 billion in Q2 2026, $3.9 billion in Q1 2026, and $3.9 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.52 Bn | 40.33 Bn | 779.09 Mn | 299.87 Mn |
| 2 | Zoetis | 30.69 Bn | 29.02 Bn | 1.05 Bn | 9.05 Bn |
| 3 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn | 3.85 Bn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 591.77 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 8.30 Mn |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - | 1.25 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.85 Bn |
| Mar 31, 2026 | 3.92 Bn |
| Dec 31, 2025 | 3.94 Bn |
| Sep 30, 2025 | 3.96 Bn |
| Jun 30, 2025 | 4.15 Bn |
| Mar 31, 2025 | 4.40 Bn |
| Dec 31, 2024 | 4.32 Bn |
| Sep 30, 2024 | 4.36 Bn |
| Jun 30, 2024 | 4.32 Bn |
| Mar 31, 2024 | 5.77 Bn |
| Dec 31, 2023 | 5.77 Bn |
| Sep 30, 2023 | 5.91 Bn |
| Jun 30, 2023 | 6.06 Bn |
| Mar 31, 2023 | 6.02 Bn |
| Dec 31, 2022 | 5.84 Bn |
| Sep 30, 2022 | 5.90 Bn |
| Jun 30, 2022 | 6.06 Bn |
| Mar 31, 2022 | 6.13 Bn |
| Dec 31, 2021 | 6.32 Bn |
| Sep 30, 2021 | 6.33 Bn |